UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q/A

(Amendment No. 1)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period ended June 30, 2023

 

Commission File No. 000-53425

 

1606 Corp.

(Name of small business issuer in its charter)

 

Nevada

 

86-1497346

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

2425 E. Camelback Rd Suite 150

Phoenix, AZ 85016

(Address of principal executive offices)

 

(602) 481-1544

(Issuer’s telephone number)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒     No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      No ☒

 

Indicate the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: As of August 11, 2023, the Company had 46,158,606 outstanding shares of its common stock, par value $0.0001.

 

 

 

 

EXPLANATORY NOTE

 

1606 Corp., a Nevada corporation (the “Company”), is filing this Quarterly Report on Form 10-Q/A, Amendment No. 1 (the “Quarterly Report on Form 10-Q/A”) to amend its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023, as filed with the Securities and Exchange Commission on August 15, 2023 (the “Original Report”). The purpose of this Quarterly Report on Form 10-Q/A is to amend the financial statements and “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.” to add accrued and unpaid salary to our CEO, Gregory Lambrecht. The remainder of the Original Report, including the financial statements and supplementary data, remains unchanged except for the inclusion of new certifications required by Rule 13a-14 under the Securities Exchange Act of 1934, as amended, as required in connection with the filing of this Quarterly Report on Form 10-Q/A.

 

We have made no attempt in this Quarterly Report on Form 10-Q/A to modify or update the disclosures presented in the Original Report other than as noted in the previous paragraph. Except as noted above, this Quarterly Report on Form 10-Q/A does not reflect events occurring after the filing of the Original Report. Accordingly, this Quarterly Report on Form 10-Q/A should be read in conjunction with the Original Report, and the Company’s other filings with the Securities and Exchange Commission (“SEC”) subsequent to the filing of the Original Report, including any amendments thereto.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2, of Part I of this report include forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by forward-looking statements.

 

In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “proposed,” “intended,” or “continue” or the negative of these terms or other comparable terminology. You should read statements that contain these words carefully, because they discuss our expectations about our future operating results or our future financial condition or state other “forward-looking” information. There may be events in the future that we are not able to accurately predict or control. Before you invest in our securities, you should be aware that the occurrence of any of the events described in this Quarterly Report could substantially harm our business, results of operations and financial condition, and that upon the occurrence of any of these events, the trading price of our securities could decline and you could lose all or part of your investment. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, growth rates, levels of activity, performance or achievements. We are under no duty to update any of the forward-looking statements after the date of this Quarterly Report to conform these statements to actual results.

 

 
2

 

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION

 

 

 

 

 

 

 

 

Item 1.

Financial Statements

 

 

 

Condensed Balance Sheets (unaudited)

 

4

 

 

Condensed Statements of Operations (unaudited)

 

5

 

 

Condensed Statements of Stockholders’ Deficit (unaudited)

 

6

 

 

Condensed Statements of Cash Flows (unaudited)

 

7

 

 

Notes to Condensed Financial Statements (unaudited)

 

8

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

13

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

15

 

Item 4.

Controls and Procedures

 

16

 

 

 

 

 

 

PART II – OTHER INFORMATION

 

 

 

 

 

 

 

 

Item 1.

Legal Proceedings

 

17

 

Item 1A.

Risk Factors

 

17

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

17

 

Item 3.

Defaults Upon Senior Securities

 

17

 

Item 4.

Mine Safety Disclosures

 

17

 

Item 5.

Other Information

 

17

 

Item 6.

Exhibits

 

18

 

Signatures

 

19

 

 

 
3

Table of Contents

 

1606 CORP.

CONDENSED BALANCE SHEETS

(unaudited)

 

 

 

 

 

 

 

 

 

June 30,

 

 

December 31,

 

 

 

2023

 

 

2022

 

ASSETS

 

 (as restated)

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash

 

$26,973

 

 

$105,065

 

Accounts Receivable

 

 

3,600

 

 

 

-

 

Notes Receivable

 

 

21,500

 

 

 

-

 

Inventory

 

 

129,202

 

 

 

113,174

 

Prepaids & Other Current Assets

 

 

-

 

 

 

13,577

 

Total Current Assets

 

 

181,275

 

 

 

231,816

 

Total Assets

 

$181,275

 

 

$231,816

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

Credit Card Payable

 

$38,395

 

 

$25,188

 

Accrued Expenses

 

 

7,083

 

 

 

-

 

Accrued Expenses - Related Party

 

 

125,000

 

 

 

 -

 

Accrued Interest Payable - Related Party

 

 

8,215

 

 

 

3,173

 

Note Payable to Shareholder

 

 

755,050

 

 

 

735,050

 

Note Payable to Related Party

 

 

63,456

 

 

 

63,456

 

Total Current Liabilities

 

 

997,199

 

 

 

826,867

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies (Note 5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Undesignated Preferred Stock, par value $0.0001; 40,000,000 authorized; no shares issued and

 

 

 

 

 

 

 

 

outstanding as of June 30, 2023 and December 31, 2022

 

 

-

 

 

 

-

 

Class A Convertible Preferred Stock, par value $0.0001 per share, 60,000,000 shares authorized;

 

 

 

 

 

 

 

 

56,632,599 and 56,635,000 shares issued and outstanding as of June 30, 2023 and

 

 

 

 

 

 

 

 

December 31, 2022, respectively

 

 

5,663

 

 

 

5,663

 

Common Stock, par value $0.0001 per share, 5,000,000,000 shares authorized, 46,158,606 and

 

 

 

 

 

 

 

 

and 37,428,394 shares issued and outstanding as of June 30, 2023 and December 31, 2022,

 

 

 

 

 

 

 

 

respectively

 

 

4,616

 

 

 

3,743

 

Additional Paid-in Capital

 

 

841,471

 

 

 

236,841

 

Accumulated Deficit

 

 

(1,667,674)

 

 

(841,298)

Total Stockholders' Deficit

 

 

(815,924)

 

 

(595,051)

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders' Deficit

 

$181,275

 

 

$231,816

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 
4

Table of Contents

 

1606 CORP.

CONDENSED STATEMENTS OF OPERATIONS

(unaudited)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30

 

 

June 30

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

 (as restated)

 

 

 

 

 

 (as restated)

 

 

 

 

Revenues, net of discounts

 

$304

 

 

$4,382

 

 

$1,474

 

 

$9,302

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

 

3,556

 

 

 

1,472

 

 

 

4,781

 

 

 

3,236

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit (loss)

 

 

(3,252)

 

 

2,910

 

 

 

(3,307)

 

 

6,066

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Write-off of investments

 

 

65,000

 

 

 

-

 

 

 

65,000

 

 

 

-

 

Selling, general and administrative

 

 

465,412

 

 

 

124,481

 

 

 

758,069

 

 

 

273,403

 

Total operating expenses

 

 

530,412

 

 

 

124,481

 

 

 

823,069

 

 

 

273,403

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before Income tax

 

 

(533,664)

 

 

(121,571)

 

 

(826,376)

 

 

(267,337)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense (benefit)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$(533,664)

 

$(121,571)

 

$(826,376)

 

$(267,337)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share - basic and diluted

 

$(0.01)

 

$(0.00)

 

$(0.02)

 

$(0.01)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding - basic and diluted

 

 

44,326,744

 

 

 

37,103,394

 

 

 

43,541,222

 

 

 

37,103,394

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 
5

Table of Contents

 

1606 Corp.

CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT

(unaudited)

 (as restated)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Additional Paid-in

 

 

Accumulated

 

 

Total Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

(Deficit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2021

 

 

56,635,000

 

 

$5,663

 

 

 

37,103,394

 

 

$3,710

 

 

$74,374

 

 

$(301,261)

 

$(217,514)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(145,766)

 

 

(145,766)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, March 31, 2022

 

 

56,635,000

 

 

$5,663

 

 

 

37,103,394

 

 

$3,710

 

 

$74,374

 

 

$(447,027)

 

$(363,280)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(121,571)

 

 

(121,571)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, June 30, 2022

 

 

56,635,000

 

 

$5,663

 

 

 

37,103,394

 

 

$3,710

 

 

$74,374

 

 

$(568,598)

 

$(484,851)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2022

 

 

56,635,000

 

 

$5,663

 

 

 

37,428,394

 

 

$3,742

 

 

$236,842

 

 

$(841,298)

 

$(595,051)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(292,712)

 

 

(292,712)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share conversions

 

 

(202,405)

 

 

(20)

 

 

5,060,125

 

 

 

506

 

 

 

(486)

 

 

-

 

 

 

-

 

Common stock issued for cash

 

 

-

 

 

 

-

 

 

 

725,000

 

 

 

73

 

 

 

412,427

 

 

 

-

 

 

 

412,500

 

Balance, March 31, 2023

 

 

56,432,595

 

 

$5,643

 

 

 

43,213,519

 

 

$4,321

 

 

$648,783

 

 

$(1,134,010)

 

$(475,263)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares issued for services provided - May 22, 2023

 

 

-

 

 

 

-

 

 

 

1,445,087

 

 

 

145

 

 

 

49,855

 

 

 

 

 

 

 

50,000

 

Shares issued for services provided - June 2, 2023

 

 

200,004

 

 

 

20

 

 

 

1,500,000

 

 

 

150

 

 

 

142,833

 

 

 

 

 

 

 

143,003

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(533,664)

 

 

(533,664)

Balance, June 30, 2023

 

 

56,632,599

 

 

$5,663

 

 

 

46,158,606

 

 

$4,616

 

 

$841,471

 

 

$(1,667,674)

 

$(815,924)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 
6

Table of Contents

 

1606 CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(unaudited)

 

 

 

 

 

 

 

 

 

Six Months Ended June 30,

 

 

 

2023

 

 

2022

 

Cash flows from operating activities:

 

 (as restated)

 

 

 

 

Net loss

 

$(826,376)

 

$(267,337)

Adjusted for Non-cash Activity:

 

 

 

 

 

 

 

 

Shares issued for services provided

 

 

193,003

 

 

 

-

 

     Write-off of investments

 

 

65,000

 

 

 

 

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts Receivable

 

 

(3,600)

 

 

(510)

Inventory

 

 

(16,028)

 

 

(62,408)

Prepaids & Other Current Assets

 

 

13,577

 

 

 

-

 

Credit Card Payable

 

 

13,207

 

 

 

-

 

Accrued Expenses

 

 

132,083

 

 

 

 

 

Accrued Interest Payable - Related Party

 

 

5,042

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

(424,092)

 

 

(330,255)

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Increase in operating companies

 

 

(65,000)

 

 

-

 

Investment in Note Receivable

 

 

(21,500)

 

 

-

 

 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

 

(86,500)

 

 

-

 

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Increase in Note Payable to Shareholder

 

 

20,000

 

 

 

340,000

 

Proceeds from sale of common stock

 

 

412,500

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net cash provided by financing activities

 

 

432,500

 

 

 

340,000

 

 

 

 

 

 

 

 

 

 

Net Change in Cash

 

 

(78,092)

 

 

9,745

 

 

 

 

 

 

 

 

 

 

Cash, beginning of the period

 

 

105,065

 

 

 

9,543

 

 

 

 

 

 

 

 

 

 

Cash, end of the period

 

$26,973

 

 

$19,288

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flows Information:

 

 

 

 

 

 

 

 

Cash paid for interest

 

$-

 

 

$-

 

Income taxes paid

 

$-

 

 

$-

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 
7

Table of Contents

 

1606 Corp.

Notes to Condensed Financial Statements

 

NOTE 1DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

 

Corporate History

 

1606 Corp. (“1606” or the “Company”) was formed in February 2021 and was a division of Singlepoint Inc. (“Singlepoint”) until April 2021, when Singlepoint spun off 1606, whereby each holder of common stock and Class A preferred stock of Singlepoint received one share of unregistered and restricted common stock or Class A Preferred Stock of the Company for each such shared owned of Singlepoint.

 

Business

 

1606 Corp. is an early-stage sales marketing company focused on the domestic hemp cigarette (aka “pre-roll”) market. The Company currently sells its hemp products through individual online sales.

 

Going Concern

 

The financial statements have been prepared assuming the Company will continue as a going concern. As of June 30, 2023, the Company has yet to achieve significant profitable operations and is dependent on its ability to raise capital from stockholders or other sources to sustain operations and to ultimately achieve viable operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company’s ability to continue in existence is dependent on its ability to develop its business and to achieve profitable operations. Since the Company does not anticipate achieving profitable operations and/or adequate cash flows in the near term, management will continue to pursue additional equity financing through private placements of the Company’s common stock.

 

NOTE 2 BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying condensed financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company’s financial position as of June 30, 2023 and December 31, 2022, and the results of the Company’s operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the financial statements and the notes included in our latest annual report on Form 10-K for the year ended December 31, 2022, and our other reports on file with the Securities and Exchange Commission (“SEC”).

 

Management believes the assumptions underlying the Company’s standalone financial statements are reasonable. Nevertheless, the financial statements may not include all the actual expenses that would have been incurred had the Company operated as a standalone company during the periods presented, and may not reflect the Company’s results of operations, financial position and cash flows had the Company operated as a standalone company during the periods presented. Actual costs that would have been incurred if the Company had operated as a standalone company would depend on multiple factors, including organizational structure and strategic decisions made in various areas.

 

Use of Estimates

 

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results may differ from those estimates.

 

Cash

 

Cash consists of highly liquid investments with an original maturity of three months or less.

 

 
8

Table of Contents

 

NOTE 2 BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Accounts Receivable and Credit Policy

 

Trade receivables due from customers are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Management of the Company considers all receivables collectable. Uncollectable accounts are charged to expense when the account is determined to be uncollectable. The allowance is provided based upon a review of the individual accounts outstanding, prior history of uncollectable accounts receivable and existing economic conditions. At June 30, 2023 and December 31, 2022, the allowance for doubtful accounts balance is $0.

 

Inventory

 

Inventories are valued at the lower of cost (first in, first out basis) or market, and consist primarily of hemp products. The Company’s inventory as of June 30, 2023, and December 31, 2022 consisted of finished hemp products. At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence, or shelf-life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand and the risk of technological or competitive obsolescence for products. To the extent that management determines there is excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value of this inventory to estimated net realizable value. No such adjustments were deemed necessary during the periods presented.

 

Investments

 

Investments are recorded at cost and evaluated for impairment each balance sheet date.  During the quarter ended June 30, 2023, the Company wrote-off investments of $15,000 and $50,000 initially made under the terms of a separate Letter of Intent and Member Interest Purchase Agreement, respectively in companies that operate in the hemp market.  See Note 5 – Commitments and Contingencies.

 

Revenue Recognition

 

The Company, which has adopted ASC 606 “Revenue from Contracts with Customers”, derives its revenues primarily from the sale of hemp products. Revenues are recognized when control of these products is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. Sales and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Any shipping and handling fees charged to customers are reported within revenue. Incidental items that are immaterial in the context of the contract are recognized as expense. The Company does not have any significant financing components as payment is received at or shortly after the point of sale.

 

Cost of Goods Sold and Selling, General and Administrative Expenses

 

Costs associated with the production and procurement of product are included in cost of goods sold, including shipping and handling costs such as inbound freight costs, purchasing, and receiving costs, inspection costs and other product procurement related charges. All other expenses are included in selling, general and administrative expenses, as the predominant expenses associated therewith are general and administrative in nature.

 

Income taxes

 

Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax bases of assets and liabilities at the applicable tax rates. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates.

 

Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by a tax authority and based upon the technical merits of the tax position. The tax benefit recognized in the financial statements for a particular tax position is based on the largest benefit that is more likely than not to be realized upon settlement. An unrecognized tax benefit, or a portion thereof, is presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed.

 

 
9

Table of Contents

 

NOTE 2 BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Net Loss Per Common Share

 

a.

Basic loss per share data is computed using the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share data is computed using the weighted-average number of common and dilutive common-equivalent shares outstanding during the period. Dilutive common-equivalent shares consist of shares that would be issued upon the exercise of stock options and other common stock equivalents, computed using the treasury stock method, and are excluded from the calculation of weighted average dilutive common shares, to the extent they are issued and outstanding, because their effect would be anti-dilutive. The number of potentially dilutive shares excluded from the calculation of diluted earnings per share were 2,265,400 related to the Company’s Class A Preferred Stock. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive.

 

 

b.

At June 30, 2023 and 2022, 46,158,606 and 37,103,394 shares of the Company’s Common Stock were outstanding, respectively. These share amounts are utilized for the calculation of basic and diluted earnings per share for the three and six month periods then ended.

 

Selling and Marketing

 

Selling and Marketing costs are expensed as incurred and are reported under selling, general and marketing in the accompanying statements of operations. Such costs were $84,892 and $19,090 for the three months ended June 30, 2023 and 2022, respectively and $122,777 and $65,678 for the six months ended June 30, 2023 and 2022, respectively.

 

Fair value measurements

 

Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:

 

Level 1 —Quoted prices for identical assets or liabilities in active markets.

 

Level 2 —Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 —Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.

 

The Company considers the carrying amounts of its financial instruments (cash, credit card payable and accrued interest payable) in the balance sheets to approximate fair value because of the short-term and/or highly liquid nature of these financial instruments.

 

Segment reporting

 

The Company operates in one business segment. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting.

 

Subsequent Events

 

The Company has evaluated all subsequent events from June 30, 2023, through the date of filing of this report.

 

Recent Accounting Pronouncements 

 

The Company has considered the potential impact of recent accounting pronouncements and has not identified any that are expected to have a material impact on the financial statements.

 

Restatement of Previously Issued Condensed Financial Statements

 

The Company has restated the accompanying condensed financial statements as of and for the three and six months ended June 30, 2023, along with certain notes to such restated condensed financial statements. The adjustments recorded were related to the correction of an error identified by management. The nature and impact of this adjustment on the Company’s previously issued condensed financial statements is summarized as follows and the effects by impacted line items are detailed in the tables below. Impacted amounts and associated disclosures are restated within the accompanying notes to the condensed financial statements.

 

The following tables summarize the effect of the restatement on each condensed financial statement line items as of and for the three and six months ended June 30, 2023.

 

 

 

As Previously Reported

 

 

Adjustments

 

 

As Restated

 

Condensed Balance Sheets as of June 30, 2023

 

 

 

 

 

 

 

 

 

Accrued Expenses - Related Party

 

$-

 

 

$125,000

 

 

$125,000

 

Total current liabilities

 

$872,119

 

 

$125,000

 

 

$997,119

 

Accumulated deficit

 

$1,542,674

 

 

$125,000

 

 

$1,667,674

 

Total stockholders’ deficit

 

$690,924

 

 

$125,000

 

 

$815,924

 

Condensed Statement of Operations for the three months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

$402,912

 

 

$62,500

 

 

$465,412

 

Total operating expenses

 

$467,912

 

 

$62,500

 

 

$530,412

 

Loss before Income tax

 

$471,164

 

 

$62,500

 

 

$533,664

 

Net loss

 

$471,164

 

 

$62,500

 

 

$533,664

 

Condensed Statement of Operations for the six months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

$633,069

 

 

$125,000

 

 

$758,069

 

Total operating expenses

 

$698,069

 

 

$125,000

 

 

$823,069

 

Loss before Income tax

 

$701,376

 

 

$125,000

 

 

$826,376

 

Net loss

 

$701,376

 

 

$125,000

 

 

$826,376

 

Condensed Statement of Cash flows for the six months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$701,376

 

 

$125,000

 

 

$826,376

 

Accrued Expenses

 

$7,083

 

 

$125,000

 

 

$132,083

 

Condensed Statements of Changes in Stockholders’ Deficit for the three months ended March 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$230,212

 

 

$62,500

 

 

$292,712

 

Accumulated deficit

 

$1,071,510

 

 

$62,500

 

 

$1,134,010

 

Total stockholders’ deficit

 

$412,763

 

 

$62,500

 

 

$475,263

 

Condensed Statements of Changes in Stockholders’ Deficit for the three months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$471,164

 

 

$62,500

 

 

$533,664

 

Accumulated deficit

 

$1,542,674

 

 

$125,000

 

 

$1,667,674

 

Total stockholders’ deficit

 

$690,924

 

 

$125,000

 

 

$815,924

 

 

 

 
10

Table of Contents

 

NOTE 3 – RELATED PARTY TRANSACTIONS

 

Related Party Transactions

 

During the quarter ended June 30, 2023, a total of 200,001 shares of Class A Preferred Stock were issued to the Company’s Vice President, Austen Lambrecht, the son of Greg Lambrecht, the Company’s Chief Executive Officer (“CEO”). In addition, one share of Class A Preferred Stock was issued to Greg Lambrecht and each of the two other members of the Company’s Board of Directors for services provided. See Note 4 – Capital Stock.

 

During the six months ended June 30, 2023, and 2022, the Company recorded $125.000 and $0, respectively, in accrued salary due to the Company’s Chief Executive Officer. 

 

During the three and six month periods ended June 30, 2023, the Company borrowed $20,000 and $0, respectively, and during the three and six months ended June 30, 2022 the Company borrowed $195,000 and $340,000, respectively in a series of cash payments from the Company’s CEO in exchange for the issuance of a promissory note. The promissory note is not secured by Company assets, does not bear interest and is due in full on December 31, 2023. The promissory note totals $755,050 at June 30, 2023.

 

In June 2021, the Company entered into an Asset Purchase Agreement with SinglePoint to purchase certain assets in exchange for the issuance of a promissory note (the “Note”) for $63,456 with SinglePoint. The Note bears interest at 5%, has a three-year term, and is due in monthly installments of $1,902 beginning August 1, 2021. The Company has not made any payments on the Note and is currently in default. Accrued interest on the Note totaled $8,215 and $3,173 at June 30, 2023 and December 31, 2022, respectively.

 

NOTE 4 – CAPITAL STOCK

 

Capital Stock

 

The Company’s authorized capital stock consists of 5,000,000,000 shares of common stock at $0.0001 par value per share and 100,000,000 shares of Preferred Stock at $0.0001 par value per share. The Company has designated 60,000,000 shares of Preferred Stock as Class A Convertible Preferred Stock (the “Class A Preferred Stock”). The remaining 40,000,000 of Preferred Stock remains undesignated.

 

Common Stock

 

The holders of common stock are entitled to one vote for each share held. The affirmative vote of a majority of votes cast at a meeting which commences with a lawful quorum is sufficient for approval of most matters upon which shareholders may or must vote, including the questions presented for approval or ratification at the Company’s Annual Shareholders’ Meeting. An amendment of the Company’s Articles of Incorporation, however, requires the affirmative vote of a majority of the Company’s total voting power for approval. Common shares do not carry cumulative voting rights, and holders of more than 50% of the common stock have the power to elect all directors and, as a practical matter, to control the Company. Holders of common stock are not entitled to preemptive rights, and the common stock may only be redeemed at the Company’s election.

 

During the quarter ended June 30, 2023, a total of 2,945,087 shares of the Company’s common stock was issued in payment for various services provided. The shares had a fair value of $83,000 based on the closing market price of the common shares on the date of grant. There were no additional shares of common stock issued during the six-month period ended June 30, 2023.

 

During the six-month period ended June 30, 2023, an additional 5,060,125 common shares were issued upon conversion of 202,405 shares of Class A Preferred Stock and 725,000 common shares were sold at $.50 per share for a total purchase price of $412,500.

 

Preferred Stock

 

As of June 30, 2023, the Company had 56,632,599 shares of Class A Preferred Stock outstanding, of which 31,092,596 shares are held by the Company’s CEO. The former officers and directors of Singlepoint hold the remaining shares of the Class A Preferred Stock.

 

The Class A Preferred Stock has certain material rights and preferences (as is more fully set forth in the Certificate of Designation of the Class A Preferred Stock).

 

During the quarter ended June 30, 2023, a total of 200,001 shares of Class A Preferred Stock was issued to the Company’s Vice President, Austen Lambrecht and one share of Class A Preferred Stock was issued to Greg Lambrecht and each of the two other members of the Company’s Board of Directors for services provided. The value of all these shares was determined to be $110,003 based on an assumed conversion at a one-for-25 ratio of the Class A Preferred Stock for common shares and the closing market price of the common shares on the date of grant.

 

During the six-month period ended June 30, 2023, an additional 202,405 shares of Class A Preferred Stock were converted into 5,060,125 common shares. No shares of the Company’s Class A Preferred Stock were issued during the quarter and six-month period ended June 30, 2022.

 

 
11

Table of Contents

 

NOTE 4 – CAPITAL STOCK (continued)

 

Ranking

 

The Class A Preferred Stock ranks, as to dividends and upon liquidation, senior and prior to the Common Stock of the Company.

 

Liquidation

 

In the event of liquidation, dissolution or winding up of the Company, the holders of the Class A Preferred Stock are entitled, out of the assets of the Company legally available for distribution, to receive, before any payment to the holders of shares of Common Stock or any other class or series of stock ranking junior, and amount per share equal to $1.00.

 

Voting

 

Each share of Class A Preferred Stock entitles the holder thereof to 50 votes on any matters requiring a shareholder vote of the Company.

 

Conversion

 

Each share of our Class A Preferred Stock is convertible into Common Stock on a one-for-25 basis at the option of the holder.

 

NOTE 5 – COMMITMENTS AND CONTINGENCIES

 

Letter of Intent

 

On February 22, 2023, the Company entered into a Letter of Intent for the acquisition of a Fifty-One Percent (51%) ownership interest in a natural therapeutic products company for total purchase consideration of $7,140,000 consisting of cash payments of $150,000 and $6,990,000 in Company common stock.  During the quarter ended June 30, 2023, the Company wrote off the initial $15,000 investment as it was determined the acquisition would not move forward and recovery of the amount was uncertain.

 

Membership Interest Purchase Agreement

 

On February 28, 2023, the Company entered into a Membership Interest Purchase Agreement for the acquisition of Fifty-One Percent (51%) of the Membership Units of a hemp distribution company for total purchase consideration consisting of 230,559 shares of the Company’s common stock and a cash payment of $50,000.  During the quarter ended June 30, 2023, the Company wrote off the initial $50,000 investment as it was determined the acquisition would not move forward and recovery of the amount was uncertain.

 

Legal Proceedings and Other Claims

 

From time to time, we are a party to claims and actions for matters arising out of our business operations. We regularly evaluate the status of the legal proceedings and other claims in which we are involved to assess whether a loss is probable or there is a reasonable possibility that a loss, or an additional loss, may have been incurred and determine if accruals are appropriate. If accruals are not appropriate, we further evaluate each legal proceeding to assess whether an estimate of possible loss or range of possible loss can be made for disclosure. Although the outcome of claims and litigation is inherently unpredictable, we believe that we have adequate provisions for any probable and estimable losses. It is possible, nevertheless, that our condensed financial position, results of operations or liquidity could be materially and adversely affected in any particular period by the resolution of a claim or legal proceeding. Legal expenses related to defense, negotiations, settlements, rulings, and advice of outside legal counsel are expensed as incurred.

 

Employment Agreements

 

In February 2023, the Company entered into an employment agreement with Austen Lambrecht. The agreement provides that Austen Lambrecht would serve as Vice President for a term of three years at an annual salary of Eighty-Five Thousand Dollars ($85,000), with an incentive bonus and stock options as determined by the Board of Directors. The agreement automatically renews for additional six-month periods unless either party has provided written termination of this Agreement at least 90 days prior to the expiration of such term. The agreement also provides for compensation under certain severance and change of control circumstance of twelve months of salary and other bonus dollars that may be due.

 

The Company has $7,083 accrued and unpaid compensation at June 30, 2023 under this agreement.

  

Employment Agreements (continued)

 

In May 2021, the Company entered into an employment agreement with Greg Lambrecht. The agreement provides that Mr. Lambrecht would serve as Chief Executive Officer Company for a term of three years at an annual salary of Two Hundred Fifty Thousand Dollars ($250,000), and an incentive bonus as determined by the Board of Directors. The agreement automatically renews for additional six-month periods unless either party has provided written termination of this Agreement at least 90 days prior to the expiration of such term.

 

Greg Lambrecht has agreed to waive his right to payment of any amounts due but unpaid under his employment contract.

 

The Company has $125,000 accrued and unpaid compensation at June 30, 2023 under this agreement.

 

 
12

Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Plan of Operation

 

The Company was incorporated in Nevada in February 2021 as a spin-off from Singlepoint Inc. in April 2021. We offer nicotine-free and tobacco-free alternatives to traditional cigarettes and vaping products. Our manufacturers use state of the art manufacturing in the United States and a blend of all-natural ingredients to provide smokers aged 21+ an alternative to traditional cigarettes that does not contain nicotine or tobacco, and promote health benefits such as pain management, reduced anxiety and enhanced wakefulness. Our smokable hemp cigarettes are an alternative for customers that currently smoke or want to quit smoking nicotine. All our hemp cigarettes are manufactured with 100% premium hemp flower and are nicotine-free, tobacco-free and organically grown – free of pesticides and other contaminants. Our key customers comprise distributors and retail customers, including convenience stores, smoke shops and individual purchasers.

 

We are focused on increasing our retail footprint concentrating on regional expansion in addition to continuing to grow our online presence and retail distribution network. We sell our products directly online through our website, www.1606hemp.com, and ship them directly to anywhere within the United States. Our products are also sold in approximately 300 retail stores.

 

With our corporate headquarters located in Phoenix, AZ and our executive team experienced in tobacco sales, distribution, commercialization, and marketing, we believe our product “1606 Original Hemp” is positioned to become the market leader in the smokable industrial hemp cigarette marketplace.

 

We have released four primary flavor variants namely Original, Smooth, Menthol, and Mango. Original is a full-flavored product which has been developed to closely emulate the taste experience of a regular tobacco cigarette. Smooth has been developed to produce a flavor profile which is milder in taste. Menthol has been developed to mimic the taste profile of a mentholated tobacco cigarette. Mango has been developed to produce a product that appeals to consumers that want a flavored product. 1606 will market its products under the 1606 Hemp brand for the Original Hemp product and under Zero for the product that has no Marijuana smell. Through the application of a flavoring treatment, they can completely transform the raw material into a finished product that tastes and smells similar to tobacco when combusted. This material is referred to as Base Cigarette Material (“BCM”). Similarly, to fine-cut tobacco, BCM is derived entirely from plant matter, however BCM is fundamentally different from fine-cut tobacco in that it has no tobacco content whatsoever. As such, BCM contains no nicotine, is non-addictive, and undergoes substantially different processing than fine-cut tobacco. This process forms a significant part of the value of Zero brand and is a closely guarded trade secret.

 

Results of Operations

 

Comparison of the Three Months Ended June 30, 2023 with the Three Months Ended June 30, 2022

 

Net Revenue. For the three months ended June 30, 2023 and 2022, we generated revenues of $304 and $4,382, respectively. The decrease in revenues was directly related to the decrease in sales of hemp cigarettes.

 

Cost of Goods Sold. For the three months ended June 30, 2023 and 2022, cost of revenue was $3,556 and $1,472, respectively. The increase was directly related to distribution of product samples in an effort to expand distribution and increase the number of retail locations that carry our products for sale.

 

Gross Profit. As a result of the foregoing, we had a negative gross profit of $(3,252) for the three months ended June 30, 2023, compared with a gross profit of $2,910 for the three months ended June 30, 2022.

 

Operating Expenses. For the three months ended June 30, 2023 and 2022, total operating expenses were $530,412 and $124,481, respectively. The increase was primarily due to write-off of investments, higher legal and professional expenses related to regulatory filings and listing of our common stock, higher advertising and marketing spend associated with efforts to expand distribution of our product offerings and higher salaries and wages.

 

Net Loss. For the three months ended June 30, 2023 and 2022, net loss was $533,664 and $121,571, respectively.  The increase in net loss was primarily due to higher operating expenses discussed above.

  

 
13

Table of Contents

 

Comparison of the Six Months Ended June 30, 2023 with the Six Months June 30, 2022

 

Net Revenue. For the six months ended June 30, 2023 and 2022, we generated revenues of $1,474 and $9,302, respectively. The decrease in revenues was due primarily to the decrease in sales of hemp cigarettes.

 

Cost of Goods Sold. For the six months ended June 30, 2023 and 2022, cost of revenue was $4,781 and $3,236, respectively. The increase was directly related to distribution of product samples in an effort to expand distribution and increase the number of retail locations that carry our products for sale.

 

Gross Profit. As a result of the foregoing, we had a negative gross profit of $(3,307) for the six months ended June 30, 2023, compared with a gross profit of $6,066 for the six months ended June 30, 2022.

 

Operating Expenses. For the six months ended June 30, 2023 and 2022, total operating expenses were $823,069 and $273,403, respectively. The increase was primarily due to write-off of investments, higher legal and professional expenses related to regulatory filings and listing of our common stock, higher advertising and marketing spend associated with efforts to expand distribution of our product offerings and higher salaries and wages.

 

Net Loss. For the six months ended June 30, 2023 and 2022, net loss was $826,376 and $267,337, respectively.  The increase in net loss was primarily due to higher operating expenses as discussed above.

  

Liquidity and Capital Resources

 

As of June 30, 2023, the Company has yet to achieve profitable operations, and while the Company hopes to achieve profitable operations in the future, if not it may need to raise capital from stockholders or other sources to sustain operations and to ultimately achieve viable operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s principal sources of liquidity have been cash provided by operating activities, as well as its ability to raise capital. The Company’s operating results for future periods are subject to numerous uncertainties and it is uncertain if the Company will be able to become profitable and continue growth for the foreseeable future. If management is not able to increase revenue and/or manage operating expenses, the Company may not be able to achieve profitability. The Company’s ability to continue in existence is dependent on the Company’s ability to achieve profitable operations.

 

To continue operations for the next 12 months, we will have a cash need of approximately $1,000,000. Should we not be able to fulfill our cash needs through the increase of revenue, we will need to raise money through outside investors through convertible notes, debt or similar instrument(s). The Company plans to pay off current liabilities through sales and increasing revenue through sales of Company services and or products, or through financing activities as mentioned above, although there is no guarantee that the Company will ultimately do so.

 

Advances from Officer

 

During the three months ended June 30, 2023, the Company borrowed $20,000 of additional funds from the Chief Executive Officer. Accordingly, the promissory note due to him increased from December 31, 2022 and totals $755,050. The note does not bear interest and is due in a lump sum payment on December 31, 2023.

 

Operating Activities

 

Cash used in operating activities – Net cash used in operating activities was $424,092 for the six months ended June 30, 2023, primarily as a result of our net loss of $826,376, reduced by $193,003 for non-cash expense associated with grants of our common and Class A Preferred shares and $65,000 for the write-off of investments.  Net cash used in operating activities was $330,255 for the six months ended June 30, 2022, primarily as a result of our net loss of $267,337.  

  

Investing Activities

 

Cash flow used in investing activities – Net cash used in investing activities during the six months ended June 30, 2023, totaled $86,500. The Company made preliminary investments of $50,000 and $15,000 in two separate operating companies which were then subsequently written-off (see Note 5 of the Notes to the Condensed Financial Statements for further details).  The $21,500 related to additional funds advanced to one of the target companies for which the Company now has Notes Receivable.  There was no cash used in investing activities during the six months ended June 30, 2022.

  

Financing Activities

 

Cash flow from financing activities – During the six months ended June 30, 2023, our financing activities provided cash of $432,500 primarily from the sale of the Company’s common stock. For the six months ended June 30, 2022, our financing activities provided cash of $340,000 resulting from additional borrowings from our Chief Executive Officer.

 

 
14

Table of Contents

 

Critical Accounting Policies

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Notes to the Condensed Financial Statements describes the significant accounting policies and methods used in the preparation of the Condensed Financial Statements. Estimates are used for, but not limited to, contingencies and taxes. Actual results could differ materially from those estimates. The following critical accounting policies are impacted significantly by judgments, assumptions, and estimates used in the preparation of the Condensed Financial Statements.

 

Loss Contingencies

 

The Company is subject to various loss contingencies arising in the ordinary course of business. The Company considers the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as its ability to reasonably estimate the amount of loss in determining loss contingencies. An estimated loss contingency is accrued when management concludes that it is probable that an asset has been impaired, or a liability has been incurred and the amount of the loss can be reasonably estimated. The Company regularly evaluates current information available to us to determine whether such accruals should be adjusted.

 

Income Taxes

 

The Company recognizes deferred tax assets (future tax benefits) and liabilities for the expected future tax consequences of temporary differences between the book carrying amounts and the tax basis of assets and liabilities. The deferred tax assets and liabilities represent the expected future tax return benefits or consequences of those differences, which are expected to be either deductible or taxable when the assets and liabilities are recovered or settled.

 

Recent Accounting Pronouncements

 

See Note 2 of the notes to the condensed financial statements for discussion of Recent Accounting Pronouncements.

 

Off-Balance Sheet Arrangements

 

We are not currently a party to, or otherwise involved with, any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Recently Adopted Accounting Standards

 

None.

 

Purchase of Significant Equipment

 

We have not previously, nor do we intend to purchase any significant equipment during the next twelve months.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Pursuant to Item 305(e) of Regulation S-K (§ 229.305(e)), the Company is not required to provide the information required by this Item as it is a “smaller reporting company,” as defined by Rule 229.10(f)(1).

 

 
15

Table of Contents

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We have performed an evaluation under the supervision and with the participation of our management, including our President and Chief Executive Officer (CEO) and Chief Financial Officer (CFO), of the effectiveness of our disclosure controls and procedures, (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2023. Based on that evaluation, our management, including our President and CEO and CFO, concluded that our disclosure controls and procedures were not effective as of June 30, 2023 to provide reasonable assurance that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer, as appropriate to allow timely decisions regarding required disclosure due to the material weaknesses described below.

 

Based on our evaluation under the framework described above, our management concluded that we had “material weaknesses” (as such term is defined below) in our control environment and financial reporting process consisting of the following as of the Evaluation Date:

 

1)

lack of a functioning audit committee resulting in ineffective oversight in the establishment and monitoring of required internal control and procedures; and

2)

inadequate segregation of duties consistent with control objectives.

 

A “material weakness” is defined under SEC rules as a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

 

A system of controls, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the system of controls are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

 

Changes in Internal Control over Financial Reporting

 

None.  

 

 
16

Table of Contents

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. Except as discussed below are not presently a party to any material litigation, nor to the knowledge of management is any litigation threatened against us, which may materially affect us.

 

Item 1A. Risk Factors

 

The Company is not required to provide the information required by this Item as it is a “smaller reporting company,” as defined by Rule 229.10(f)(1).

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

None.

 

Item 5. Other Information

 

None.

 

 
17

Table of Contents

 

Item 6. Exhibits

 

Exhibit

Number

 

Name of Exhibit

31.1

Certification of Chief Executive Officer, pursuant to Rule 13a-14(a) of the Exchange Act, as enacted by Section 302 of the Sarbanes-Oxley Act of 2002. (1)

 

 

 

31.2

Certification of Chief Financial Officer, pursuant to Rule 13a-14(a) of the Exchange Act, as enacted by Section 302 of the Sarbanes-Oxley Act of 2002. (1)

 

 

 

32.1

Certification of Chief Executive Officer and Chief Financial Officer, pursuant to 18 United States Code Section 1350, as enacted by Section 906 of the Sarbanes-Oxley Act of 2002. (1)

 

 

 

101.INS

 

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH

 

Inline XBRL Taxonomy Extension Schema

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase

104

 

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

________________

(1) Filed herewith.  In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 34-47986, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act or deemed to be incorporated by reference into any filing under the Exchange Act or the Securities Act except to the extent that the registrant specifically incorporates it by reference.

 

 
18

Table of Contents

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

1606 Corp.

 

 

 

 

 

Dated: April xx, 2024

By:

/s/ Gregory Lambrecht

 

 

 

Gregory Lambrecht

 

 

 

Chief Executive Officer, Chief Financial Officer, Director

 

 

 
19

 

nullnullnullv3.24.1.1.u2
Cover - shares
6 Months Ended
Jun. 30, 2023
Aug. 11, 2023
Cover [Abstract]    
Entity Registrant Name 1606 Corp.  
Entity Central Index Key 0001877461  
Document Type 10-Q/A  
Amendment Flag true  
Current Fiscal Year End Date --12-31  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company true  
Entity Current Reporting Status Yes  
Document Period End Date Jun. 30, 2023  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Entity Ex Transition Period false  
Entity Common Stock Shares Outstanding   46,158,606
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-53425  
Entity Incorporation State Country Code NV  
Entity Tax Identification Number 86-1497346  
Entity Address Address Line 1 2425 E. Camelback Rd Suite 150  
Entity Address City Or Town Phoenix  
Entity Address State Or Province AZ  
Entity Address Postal Zip Code 85016  
City Area Code 602  
Local Phone Number 481-1544  
Entity Interactive Data Current Yes  
Amendment Description 1606 Corp., a Nevada corporation (the “Company”), is filing this Quarterly Report on Form 10-Q/A, Amendment No. 1 (the “Quarterly Report on Form 10-Q/A”) to amend its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023, as filed with the Securities and Exchange Commission on August 15, 2023 (the “Original Report”). The purpose of this Quarterly Report on Form 10-Q/A is to amend the financial statements and “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.” to add accrued and unpaid salary to our CEO, Gregory Lambrecht. The remainder of the Original Report, including the financial statements and supplementary data, remains unchanged except for the inclusion of new certifications required by Rule 13a-14 under the Securities Exchange Act of 1934, as amended, as required in connection with the filing of this Quarterly Report on Form 10-Q/A.  
v3.24.1.1.u2
CONDENSED BALANCE SHEETS - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Cash $ 26,973 $ 105,065
Current Assets:    
Accounts Receivable 3,600 0
Note Receivable 21,500 0
Inventory 129,202 113,174
Prepaids and other current assets 0 13,577
Total Current Assets 181,275 231,816
Total Assets 181,275 231,816
Current Liabilities:    
Credit card payable 38,395 25,188
Accrued Expenses 7,083 0
Accrued Expenses - Related Party 125,000 0
Accrued interest payable - related party 8,215 3,173
Note payable to related party 63,456 63,456
Note Payable to Shareholder 755,050 735,050
Total current liabilities 997,199 826,867
Stockholders' Equity (Deficit):    
Common Stock, par value $0.0001 per share, 5,000,000,000 shares authorized, 43,213,519 and 37,428,394 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 4,616 3,743
Additional paid-in capital 841,471 236,841
Accumulated deficit (1,667,674) (841,298)
Total stockholders' deficit (815,924) (595,051)
Total liabilities and stockholders' deficit 181,275 231,816
Undesignated Preferred Stock [Member]    
Stockholders' Equity (Deficit):    
Preferred stock 0 0
Class A Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficit):    
Preferred stock $ 5,663 $ 5,663
v3.24.1.1.u2
CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 5,000,000,000 5,000,000,000
Common stock, shares issued 46,158,606 37,428,394
Common stock, shares outstanding 46,158,606 37,103,394
Preferred stock, par value $ 0.0001  
Preferred stock, shares authorized 100,000,000  
Undesignated Preferred Stock [Member]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 40,000,000 40,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Class A Convertible Preferred Stock [Member]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 60,000,000 60,000,000
Preferred stock, shares issued 56,632,599 56,635,000
Preferred stock, shares outstanding 56,632,599 56,635,000
v3.24.1.1.u2
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
CONDENSED STATEMENTS OF OPERATIONS (Unaudited)        
Revenues, net of discounts $ 304 $ 4,382 $ 1,474 $ 9,302
Cost of goods sold 3,556 1,472 4,781 3,236
Gross profit (loss) (3,252) 2,910 (3,307) 6,066
Operating expenses:        
Write-off of investments 65,000 0 65,000 0
Selling, general and administrative 465,412 124,481 758,069 273,403
Total operating expenses 530,412 124,481 823,069 273,403
Loss before Income tax (533,664) (121,571) (826,376) (267,337)
Income tax expense (benefit) 0 0 0 0
Net loss $ (533,664) $ (121,571) $ (826,376) $ (267,337)
Net loss per share - basic and diluted $ (0.01) $ (0.00) $ (0.02) $ (0.01)
Weighted average shares outstanding - basic and diluted 44,326,744 37,103,394 43,541,222 37,103,394
v3.24.1.1.u2
CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2021   56,635,000 37,103,394    
Balance, amount at Dec. 31, 2021 $ (217,514) $ 5,663 $ 3,710 $ 74,374 $ (301,261)
Net loss (145,766) $ 0 $ 0 0 (145,766)
Balance, shares at Mar. 31, 2022   56,635,000 37,103,394    
Balance, amount at Mar. 31, 2022 (363,280) $ 5,663 $ 3,710 74,374 (447,027)
Balance, shares at Dec. 31, 2021   56,635,000 37,103,394    
Balance, amount at Dec. 31, 2021 (217,514) $ 5,663 $ 3,710 74,374 (301,261)
Net loss (267,337)        
Balance, shares at Jun. 30, 2022   56,635,000 37,103,394    
Balance, amount at Jun. 30, 2022 (484,851) $ 5,663 $ 3,710 74,374 (568,598)
Balance, shares at Mar. 31, 2022   56,635,000 37,103,394    
Balance, amount at Mar. 31, 2022 (363,280) $ 5,663 $ 3,710 74,374 (447,027)
Net loss (121,571) $ 0 $ 0 0 (121,571)
Balance, shares at Jun. 30, 2022   56,635,000 37,103,394    
Balance, amount at Jun. 30, 2022 (484,851) $ 5,663 $ 3,710 74,374 (568,598)
Balance, shares at Dec. 31, 2022   56,635,000 37,428,394    
Balance, amount at Dec. 31, 2022 (595,051) $ 5,663 $ 3,742 236,842 (841,298)
Net loss (292,712) $ 0 $ 0 0 (292,712)
Share conversions, shares   (202,405) 5,060,125    
Share conversions, amount 0 $ (20) $ 506 (486) 0
Common stock issued for cash, shares     725,000    
Common stock issued for cash, amount 412,500 $ 0 $ 73 412,427 0
Balance, shares at Mar. 31, 2023   56,432,595 43,213,519    
Balance, amount at Mar. 31, 2023 (475,263) $ 5,643 $ 4,321 648,783 (1,134,010)
Balance, shares at Dec. 31, 2022   56,635,000 37,428,394    
Balance, amount at Dec. 31, 2022 (595,051) $ 5,663 $ 3,742 236,842 (841,298)
Net loss (826,376)        
Balance, shares at Jun. 30, 2023   56,632,599 46,158,606    
Balance, amount at Jun. 30, 2023 (815,924) $ 5,663 $ 4,616 841,471 (1,667,674)
Balance, shares at Mar. 31, 2023   56,432,595 43,213,519    
Balance, amount at Mar. 31, 2023 (475,263) $ 5,643 $ 4,321 648,783 (1,134,010)
Net loss (533,664) $ 0 $ 0 0 (533,664)
Shares issued for services provided - May 22, 2023, shares     1,445,087    
Shares issued for services provided - May 22, 2023, amount 50,000   $ 145 49,855  
Shares issued for services provided - June 2, 2023, shares   200,004 1,500,000    
Shares issued for services provided - June 2, 2023, amount 143,003 $ 20 $ 150 142,833  
Balance, shares at Jun. 30, 2023   56,632,599 46,158,606    
Balance, amount at Jun. 30, 2023 $ (815,924) $ 5,663 $ 4,616 $ 841,471 $ (1,667,674)
v3.24.1.1.u2
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net loss $ (826,376) $ (267,337)
Adjusted for Non-cash Activity:    
Shares issued for services provided 193,003 0
Write-off of investments 65,000 0
Changes in operating assets and liabilities:    
Accounts Receivable (3,600) (510)
Inventory (16,028) (62,408)
Prepaids & Other Current Assets 13,577 0
Credit Card Payable 13,207 0
Accrued Expenses 132,083  
Accrued Interest Payable - Related Party 5,042 0
Net cash used in operating activities (424,092) (330,255)
Cash flows from investing activities:    
Investment in operating companies 65,000 0
Increase in Note Receivable 21,500 0
Net cash used in investing activities (86,500) 0
Cash flows from financing activities:    
Increase in Note Payable to Shareholder 20,000 340,000
Proceeds from sale of common stock 412,500 0
Net cash provided by financing activities 432,500 340,000
Net Change in Cash (78,092) 9,745
Cash, beginning of the period 105,065 9,543
Supplemental Disclosure of Cash Flows Information:    
Cash paid for interest 0 0
Income taxes paid $ 0 $ 0
v3.24.1.1.u2
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
6 Months Ended
Jun. 30, 2023
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION  
DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

NOTE 1DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

 

Corporate History

 

1606 Corp. (“1606” or the “Company”) was formed in February 2021 and was a division of Singlepoint Inc. (“Singlepoint”) until April 2021, when Singlepoint spun off 1606, whereby each holder of common stock and Class A preferred stock of Singlepoint received one share of unregistered and restricted common stock or Class A Preferred Stock of the Company for each such shared owned of Singlepoint.

 

Business

 

1606 Corp. is an early-stage sales marketing company focused on the domestic hemp cigarette (aka “pre-roll”) market. The Company currently sells its hemp products through individual online sales.

 

Going Concern

 

The financial statements have been prepared assuming the Company will continue as a going concern. As of June 30, 2023, the Company has yet to achieve significant profitable operations and is dependent on its ability to raise capital from stockholders or other sources to sustain operations and to ultimately achieve viable operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company’s ability to continue in existence is dependent on its ability to develop its business and to achieve profitable operations. Since the Company does not anticipate achieving profitable operations and/or adequate cash flows in the near term, management will continue to pursue additional equity financing through private placements of the Company’s common stock.

v3.24.1.1.u2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2023
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying condensed financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company’s financial position as of June 30, 2023 and December 31, 2022, and the results of the Company’s operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the financial statements and the notes included in our latest annual report on Form 10-K for the year ended December 31, 2022, and our other reports on file with the Securities and Exchange Commission (“SEC”).

 

Management believes the assumptions underlying the Company’s standalone financial statements are reasonable. Nevertheless, the financial statements may not include all the actual expenses that would have been incurred had the Company operated as a standalone company during the periods presented, and may not reflect the Company’s results of operations, financial position and cash flows had the Company operated as a standalone company during the periods presented. Actual costs that would have been incurred if the Company had operated as a standalone company would depend on multiple factors, including organizational structure and strategic decisions made in various areas.

 

Use of Estimates

 

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results may differ from those estimates.

 

Cash

 

Cash consists of highly liquid investments with an original maturity of three months or less.

Accounts Receivable and Credit Policy

 

Trade receivables due from customers are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Management of the Company considers all receivables collectable. Uncollectable accounts are charged to expense when the account is determined to be uncollectable. The allowance is provided based upon a review of the individual accounts outstanding, prior history of uncollectable accounts receivable and existing economic conditions. At June 30, 2023 and December 31, 2022, the allowance for doubtful accounts balance is $0.

 

Inventory

 

Inventories are valued at the lower of cost (first in, first out basis) or market, and consist primarily of hemp products. The Company’s inventory as of June 30, 2023, and December 31, 2022 consisted of finished hemp products. At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence, or shelf-life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand and the risk of technological or competitive obsolescence for products. To the extent that management determines there is excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value of this inventory to estimated net realizable value. No such adjustments were deemed necessary during the periods presented.

 

Investments

 

Investments are recorded at cost and evaluated for impairment each balance sheet date.  During the quarter ended June 30, 2023, the Company wrote-off investments of $15,000 and $50,000 initially made under the terms of a separate Letter of Intent and Member Interest Purchase Agreement, respectively in companies that operate in the hemp market.  See Note 5 – Commitments and Contingencies.

 

Revenue Recognition

 

The Company, which has adopted ASC 606 “Revenue from Contracts with Customers”, derives its revenues primarily from the sale of hemp products. Revenues are recognized when control of these products is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. Sales and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Any shipping and handling fees charged to customers are reported within revenue. Incidental items that are immaterial in the context of the contract are recognized as expense. The Company does not have any significant financing components as payment is received at or shortly after the point of sale.

 

Cost of Goods Sold and Selling, General and Administrative Expenses

 

Costs associated with the production and procurement of product are included in cost of goods sold, including shipping and handling costs such as inbound freight costs, purchasing, and receiving costs, inspection costs and other product procurement related charges. All other expenses are included in selling, general and administrative expenses, as the predominant expenses associated therewith are general and administrative in nature.

 

Income taxes

 

Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax bases of assets and liabilities at the applicable tax rates. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates.

 

Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by a tax authority and based upon the technical merits of the tax position. The tax benefit recognized in the financial statements for a particular tax position is based on the largest benefit that is more likely than not to be realized upon settlement. An unrecognized tax benefit, or a portion thereof, is presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed.

Net Loss Per Common Share

 

a.

Basic loss per share data is computed using the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share data is computed using the weighted-average number of common and dilutive common-equivalent shares outstanding during the period. Dilutive common-equivalent shares consist of shares that would be issued upon the exercise of stock options and other common stock equivalents, computed using the treasury stock method, and are excluded from the calculation of weighted average dilutive common shares, to the extent they are issued and outstanding, because their effect would be anti-dilutive. The number of potentially dilutive shares excluded from the calculation of diluted earnings per share were 2,265,400 related to the Company’s Class A Preferred Stock. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive.

 

 

b.

At June 30, 2023 and 2022, 46,158,606 and 37,103,394 shares of the Company’s Common Stock were outstanding, respectively. These share amounts are utilized for the calculation of basic and diluted earnings per share for the three and six month periods then ended.

 

Selling and Marketing

 

Selling and Marketing costs are expensed as incurred and are reported under selling, general and marketing in the accompanying statements of operations. Such costs were $84,892 and $19,090 for the three months ended June 30, 2023 and 2022, respectively and $122,777 and $65,678 for the six months ended June 30, 2023 and 2022, respectively.

 

Fair value measurements

 

Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:

 

Level 1 —Quoted prices for identical assets or liabilities in active markets.

 

Level 2 —Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 —Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.

 

The Company considers the carrying amounts of its financial instruments (cash, credit card payable and accrued interest payable) in the balance sheets to approximate fair value because of the short-term and/or highly liquid nature of these financial instruments.

 

Segment reporting

 

The Company operates in one business segment. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting.

 

Subsequent Events

 

The Company has evaluated all subsequent events from June 30, 2023, through the date of filing of this report.

 

Recent Accounting Pronouncements 

 

The Company has considered the potential impact of recent accounting pronouncements and has not identified any that are expected to have a material impact on the financial statements.

 

Restatement of Previously Issued Condensed Financial Statements

 

The Company has restated the accompanying condensed financial statements as of and for the three and six months ended June 30, 2023, along with certain notes to such restated condensed financial statements. The adjustments recorded were related to the correction of an error identified by management. The nature and impact of this adjustment on the Company’s previously issued condensed financial statements is summarized as follows and the effects by impacted line items are detailed in the tables below. Impacted amounts and associated disclosures are restated within the accompanying notes to the condensed financial statements.

 

The following tables summarize the effect of the restatement on each condensed financial statement line items as of and for the three and six months ended June 30, 2023.

 

 

 

As Previously Reported

 

 

Adjustments

 

 

As Restated

 

Condensed Balance Sheets as of June 30, 2023

 

 

 

 

 

 

 

 

 

Accrued Expenses - Related Party

 

$-

 

 

$125,000

 

 

$125,000

 

Total current liabilities

 

$872,119

 

 

$125,000

 

 

$997,119

 

Accumulated deficit

 

$1,542,674

 

 

$125,000

 

 

$1,667,674

 

Total stockholders’ deficit

 

$690,924

 

 

$125,000

 

 

$815,924

 

Condensed Statement of Operations for the three months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

$402,912

 

 

$62,500

 

 

$465,412

 

Total operating expenses

 

$467,912

 

 

$62,500

 

 

$530,412

 

Loss before Income tax

 

$471,164

 

 

$62,500

 

 

$533,664

 

Net loss

 

$471,164

 

 

$62,500

 

 

$533,664

 

Condensed Statement of Operations for the six months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

$633,069

 

 

$125,000

 

 

$758,069

 

Total operating expenses

 

$698,069

 

 

$125,000

 

 

$823,069

 

Loss before Income tax

 

$701,376

 

 

$125,000

 

 

$826,376

 

Net loss

 

$701,376

 

 

$125,000

 

 

$826,376

 

Condensed Statement of Cash flows for the six months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$701,376

 

 

$125,000

 

 

$826,376

 

Accrued Expenses

 

$7,083

 

 

$125,000

 

 

$132,083

 

Condensed Statements of Changes in Stockholders’ Deficit for the three months ended March 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$230,212

 

 

$62,500

 

 

$292,712

 

Accumulated deficit

 

$1,071,510

 

 

$62,500

 

 

$1,134,010

 

Total stockholders’ deficit

 

$412,763

 

 

$62,500

 

 

$475,263

 

Condensed Statements of Changes in Stockholders’ Deficit for the three months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$471,164

 

 

$62,500

 

 

$533,664

 

Accumulated deficit

 

$1,542,674

 

 

$125,000

 

 

$1,667,674

 

Total stockholders’ deficit

 

$690,924

 

 

$125,000

 

 

$815,924

 

 

v3.24.1.1.u2
RELATED PARTY TRANSACTIONS
6 Months Ended
Jun. 30, 2023
RELATED PARTY TRANSACTIONS  
RELATED PARTY TRANSACTIONS

NOTE 3 – RELATED PARTY TRANSACTIONS

 

Related Party Transactions

 

During the quarter ended June 30, 2023, a total of 200,001 shares of Class A Preferred Stock were issued to the Company’s Vice President, Austen Lambrecht, the son of Greg Lambrecht, the Company’s Chief Executive Officer (“CEO”). In addition, one share of Class A Preferred Stock was issued to Greg Lambrecht and each of the two other members of the Company’s Board of Directors for services provided. See Note 4 – Capital Stock.

 

During the six months ended June 30, 2023, and 2022, the Company recorded $125.000 and $0, respectively, in accrued salary due to the Company’s Chief Executive Officer. 

 

During the three and six month periods ended June 30, 2023, the Company borrowed $20,000 and $0, respectively, and during the three and six months ended June 30, 2022 the Company borrowed $195,000 and $340,000, respectively in a series of cash payments from the Company’s CEO in exchange for the issuance of a promissory note. The promissory note is not secured by Company assets, does not bear interest and is due in full on December 31, 2023. The promissory note totals $755,050 at June 30, 2023.

 

In June 2021, the Company entered into an Asset Purchase Agreement with SinglePoint to purchase certain assets in exchange for the issuance of a promissory note (the “Note”) for $63,456 with SinglePoint. The Note bears interest at 5%, has a three-year term, and is due in monthly installments of $1,902 beginning August 1, 2021. The Company has not made any payments on the Note and is currently in default. Accrued interest on the Note totaled $8,215 and $3,173 at June 30, 2023 and December 31, 2022, respectively.

v3.24.1.1.u2
CAPITAL STOCK
6 Months Ended
Jun. 30, 2023
CAPITAL STOCK  
CAPITAL STOCK

NOTE 4 – CAPITAL STOCK

 

Capital Stock

 

The Company’s authorized capital stock consists of 5,000,000,000 shares of common stock at $0.0001 par value per share and 100,000,000 shares of Preferred Stock at $0.0001 par value per share. The Company has designated 60,000,000 shares of Preferred Stock as Class A Convertible Preferred Stock (the “Class A Preferred Stock”). The remaining 40,000,000 of Preferred Stock remains undesignated.

 

Common Stock

 

The holders of common stock are entitled to one vote for each share held. The affirmative vote of a majority of votes cast at a meeting which commences with a lawful quorum is sufficient for approval of most matters upon which shareholders may or must vote, including the questions presented for approval or ratification at the Company’s Annual Shareholders’ Meeting. An amendment of the Company’s Articles of Incorporation, however, requires the affirmative vote of a majority of the Company’s total voting power for approval. Common shares do not carry cumulative voting rights, and holders of more than 50% of the common stock have the power to elect all directors and, as a practical matter, to control the Company. Holders of common stock are not entitled to preemptive rights, and the common stock may only be redeemed at the Company’s election.

 

During the quarter ended June 30, 2023, a total of 2,945,087 shares of the Company’s common stock was issued in payment for various services provided. The shares had a fair value of $83,000 based on the closing market price of the common shares on the date of grant. There were no additional shares of common stock issued during the six-month period ended June 30, 2023.

 

During the six-month period ended June 30, 2023, an additional 5,060,125 common shares were issued upon conversion of 202,405 shares of Class A Preferred Stock and 725,000 common shares were sold at $.50 per share for a total purchase price of $412,500.

 

Preferred Stock

 

As of June 30, 2023, the Company had 56,632,599 shares of Class A Preferred Stock outstanding, of which 31,092,596 shares are held by the Company’s CEO. The former officers and directors of Singlepoint hold the remaining shares of the Class A Preferred Stock.

 

The Class A Preferred Stock has certain material rights and preferences (as is more fully set forth in the Certificate of Designation of the Class A Preferred Stock).

 

During the quarter ended June 30, 2023, a total of 200,001 shares of Class A Preferred Stock was issued to the Company’s Vice President, Austen Lambrecht and one share of Class A Preferred Stock was issued to Greg Lambrecht and each of the two other members of the Company’s Board of Directors for services provided. The value of all these shares was determined to be $110,003 based on an assumed conversion at a one-for-25 ratio of the Class A Preferred Stock for common shares and the closing market price of the common shares on the date of grant.

 

During the six-month period ended June 30, 2023, an additional 202,405 shares of Class A Preferred Stock were converted into 5,060,125 common shares. No shares of the Company’s Class A Preferred Stock were issued during the quarter and six-month period ended June 30, 2022.

Ranking

 

The Class A Preferred Stock ranks, as to dividends and upon liquidation, senior and prior to the Common Stock of the Company.

 

Liquidation

 

In the event of liquidation, dissolution or winding up of the Company, the holders of the Class A Preferred Stock are entitled, out of the assets of the Company legally available for distribution, to receive, before any payment to the holders of shares of Common Stock or any other class or series of stock ranking junior, and amount per share equal to $1.00.

 

Voting

 

Each share of Class A Preferred Stock entitles the holder thereof to 50 votes on any matters requiring a shareholder vote of the Company.

 

Conversion

 

Each share of our Class A Preferred Stock is convertible into Common Stock on a one-for-25 basis at the option of the holder.

v3.24.1.1.u2
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2023
COMMITMENTS AND CONTINGENCIES  
COMMITMENTS AND CONTINGENCIES

NOTE 5 – COMMITMENTS AND CONTINGENCIES

 

Letter of Intent

 

On February 22, 2023, the Company entered into a Letter of Intent for the acquisition of a Fifty-One Percent (51%) ownership interest in a natural therapeutic products company for total purchase consideration of $7,140,000 consisting of cash payments of $150,000 and $6,990,000 in Company common stock.  During the quarter ended June 30, 2023, the Company wrote off the initial $15,000 investment as it was determined the acquisition would not move forward and recovery of the amount was uncertain.

 

Membership Interest Purchase Agreement

 

On February 28, 2023, the Company entered into a Membership Interest Purchase Agreement for the acquisition of Fifty-One Percent (51%) of the Membership Units of a hemp distribution company for total purchase consideration consisting of 230,559 shares of the Company’s common stock and a cash payment of $50,000.  During the quarter ended June 30, 2023, the Company wrote off the initial $50,000 investment as it was determined the acquisition would not move forward and recovery of the amount was uncertain.

 

Legal Proceedings and Other Claims

 

From time to time, we are a party to claims and actions for matters arising out of our business operations. We regularly evaluate the status of the legal proceedings and other claims in which we are involved to assess whether a loss is probable or there is a reasonable possibility that a loss, or an additional loss, may have been incurred and determine if accruals are appropriate. If accruals are not appropriate, we further evaluate each legal proceeding to assess whether an estimate of possible loss or range of possible loss can be made for disclosure. Although the outcome of claims and litigation is inherently unpredictable, we believe that we have adequate provisions for any probable and estimable losses. It is possible, nevertheless, that our condensed financial position, results of operations or liquidity could be materially and adversely affected in any particular period by the resolution of a claim or legal proceeding. Legal expenses related to defense, negotiations, settlements, rulings, and advice of outside legal counsel are expensed as incurred.

 

Employment Agreements

 

In February 2023, the Company entered into an employment agreement with Austen Lambrecht. The agreement provides that Austen Lambrecht would serve as Vice President for a term of three years at an annual salary of Eighty-Five Thousand Dollars ($85,000), with an incentive bonus and stock options as determined by the Board of Directors. The agreement automatically renews for additional six-month periods unless either party has provided written termination of this Agreement at least 90 days prior to the expiration of such term. The agreement also provides for compensation under certain severance and change of control circumstance of twelve months of salary and other bonus dollars that may be due.

 

The Company has $7,083 accrued and unpaid compensation at June 30, 2023 under this agreement.

  

Employment Agreements (continued)

 

In May 2021, the Company entered into an employment agreement with Greg Lambrecht. The agreement provides that Mr. Lambrecht would serve as Chief Executive Officer Company for a term of three years at an annual salary of Two Hundred Fifty Thousand Dollars ($250,000), and an incentive bonus as determined by the Board of Directors. The agreement automatically renews for additional six-month periods unless either party has provided written termination of this Agreement at least 90 days prior to the expiration of such term.

 

Greg Lambrecht has agreed to waive his right to payment of any amounts due but unpaid under his employment contract.

 

The Company has $125,000 accrued and unpaid compensation at June 30, 2023 under this agreement.

v3.24.1.1.u2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2023
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Investments

Investments are recorded at cost and evaluated for impairment each balance sheet date.  During the quarter ended June 30, 2023, the Company wrote-off investments of $15,000 and $50,000 initially made under the terms of a separate Letter of Intent and Member Interest Purchase Agreement, respectively in companies that operate in the hemp market.  See Note 5 – Commitments and Contingencies.

Basis of Presentation

The accompanying condensed financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly the Company’s financial position as of June 30, 2023 and December 31, 2022, and the results of the Company’s operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the financial statements and the notes included in our latest annual report on Form 10-K for the year ended December 31, 2022, and our other reports on file with the Securities and Exchange Commission (“SEC”).

 

Management believes the assumptions underlying the Company’s standalone financial statements are reasonable. Nevertheless, the financial statements may not include all the actual expenses that would have been incurred had the Company operated as a standalone company during the periods presented, and may not reflect the Company’s results of operations, financial position and cash flows had the Company operated as a standalone company during the periods presented. Actual costs that would have been incurred if the Company had operated as a standalone company would depend on multiple factors, including organizational structure and strategic decisions made in various areas.

Use of Estimates

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results may differ from those estimates.

Cash and Cash Equivalents

Cash consists of highly liquid investments with an original maturity of three months or less.

Accounts Receivable and Credit Policy

Trade receivables due from customers are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days from the invoice date. Management of the Company considers all receivables collectable. Uncollectable accounts are charged to expense when the account is determined to be uncollectable. The allowance is provided based upon a review of the individual accounts outstanding, prior history of uncollectable accounts receivable and existing economic conditions. At June 30, 2023 and December 31, 2022, the allowance for doubtful accounts balance is $0.

Inventory

Inventories are valued at the lower of cost (first in, first out basis) or market, and consist primarily of hemp products. The Company’s inventory as of June 30, 2023, and December 31, 2022 consisted of finished hemp products. At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence, or shelf-life expiration. This evaluation includes analysis of historical sales levels by product, projections of future demand and the risk of technological or competitive obsolescence for products. To the extent that management determines there is excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value of this inventory to estimated net realizable value. No such adjustments were deemed necessary during the periods presented.

Revenue Recognition

The Company, which has adopted ASC 606 “Revenue from Contracts with Customers”, derives its revenues primarily from the sale of hemp products. Revenues are recognized when control of these products is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. Sales and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. Any shipping and handling fees charged to customers are reported within revenue. Incidental items that are immaterial in the context of the contract are recognized as expense. The Company does not have any significant financing components as payment is received at or shortly after the point of sale.

Cost of Goods Sold and Selling, General and Administrative Expenses

Costs associated with the production and procurement of product are included in cost of goods sold, including shipping and handling costs such as inbound freight costs, purchasing, and receiving costs, inspection costs and other product procurement related charges. All other expenses are included in selling, general and administrative expenses, as the predominant expenses associated therewith are general and administrative in nature.

Income Taxes

Income taxes are accounted for using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement and tax bases of assets and liabilities at the applicable tax rates. Deferred tax assets are reduced by a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates.

 

Tax benefits are recognized from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by a tax authority and based upon the technical merits of the tax position. The tax benefit recognized in the financial statements for a particular tax position is based on the largest benefit that is more likely than not to be realized upon settlement. An unrecognized tax benefit, or a portion thereof, is presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed.

Net Loss Per Common Share

a.

Basic loss per share data is computed using the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share data is computed using the weighted-average number of common and dilutive common-equivalent shares outstanding during the period. Dilutive common-equivalent shares consist of shares that would be issued upon the exercise of stock options and other common stock equivalents, computed using the treasury stock method, and are excluded from the calculation of weighted average dilutive common shares, to the extent they are issued and outstanding, because their effect would be anti-dilutive. The number of potentially dilutive shares excluded from the calculation of diluted earnings per share were 2,265,400 related to the Company’s Class A Preferred Stock. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive.

 

 

b.

At June 30, 2023 and 2022, 46,158,606 and 37,103,394 shares of the Company’s Common Stock were outstanding, respectively. These share amounts are utilized for the calculation of basic and diluted earnings per share for the three and six month periods then ended.

Selling and Marketing

Selling and Marketing costs are expensed as incurred and are reported under selling, general and marketing in the accompanying statements of operations. Such costs were $84,892 and $19,090 for the three months ended June 30, 2023 and 2022, respectively and $122,777 and $65,678 for the six months ended June 30, 2023 and 2022, respectively.

Fair Value measurements

Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources, while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The basis for fair value measurements for each level within the hierarchy is described below:

 

Level 1 —Quoted prices for identical assets or liabilities in active markets.

 

Level 2 —Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or model-derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 —Valuations derived from valuation techniques in which one or more significant inputs to the valuation model are unobservable.

 

The Company considers the carrying amounts of its financial instruments (cash, credit card payable and accrued interest payable) in the balance sheets to approximate fair value because of the short-term and/or highly liquid nature of these financial instruments.

Segment reporting

The Company operates in one business segment. As a result, the Company’s operations are a single reportable segment, which is consistent with the Company’s internal management reporting.

Subsequent Events

The Company has evaluated all subsequent events from June 30, 2023, through the date of filing of this report.

Recent Accounting Pronouncements

The Company has considered the potential impact of recent accounting pronouncements and has not identified any that are expected to have a material impact on the financial statements.

Restatement of Previously Issued Condensed Financial Statements

The Company has restated the accompanying condensed financial statements as of and for the three and six months ended June 30, 2023, along with certain notes to such restated condensed financial statements. The adjustments recorded were related to the correction of an error identified by management. The nature and impact of this adjustment on the Company’s previously issued condensed financial statements is summarized as follows and the effects by impacted line items are detailed in the tables below. Impacted amounts and associated disclosures are restated within the accompanying notes to the condensed financial statements.

 

The following tables summarize the effect of the restatement on each condensed financial statement line items as of and for the three and six months ended June 30, 2023.

 

 

 

As Previously Reported

 

 

Adjustments

 

 

As Restated

 

Condensed Balance Sheets as of June 30, 2023

 

 

 

 

 

 

 

 

 

Accrued Expenses - Related Party

 

$-

 

 

$125,000

 

 

$125,000

 

Total current liabilities

 

$872,119

 

 

$125,000

 

 

$997,119

 

Accumulated deficit

 

$1,542,674

 

 

$125,000

 

 

$1,667,674

 

Total stockholders’ deficit

 

$690,924

 

 

$125,000

 

 

$815,924

 

Condensed Statement of Operations for the three months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

$402,912

 

 

$62,500

 

 

$465,412

 

Total operating expenses

 

$467,912

 

 

$62,500

 

 

$530,412

 

Loss before Income tax

 

$471,164

 

 

$62,500

 

 

$533,664

 

Net loss

 

$471,164

 

 

$62,500

 

 

$533,664

 

Condensed Statement of Operations for the six months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

$633,069

 

 

$125,000

 

 

$758,069

 

Total operating expenses

 

$698,069

 

 

$125,000

 

 

$823,069

 

Loss before Income tax

 

$701,376

 

 

$125,000

 

 

$826,376

 

Net loss

 

$701,376

 

 

$125,000

 

 

$826,376

 

Condensed Statement of Cash flows for the six months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$701,376

 

 

$125,000

 

 

$826,376

 

Accrued Expenses

 

$7,083

 

 

$125,000

 

 

$132,083

 

Condensed Statements of Changes in Stockholders’ Deficit for the three months ended March 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$230,212

 

 

$62,500

 

 

$292,712

 

Accumulated deficit

 

$1,071,510

 

 

$62,500

 

 

$1,134,010

 

Total stockholders’ deficit

 

$412,763

 

 

$62,500

 

 

$475,263

 

Condensed Statements of Changes in Stockholders’ Deficit for the three months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$471,164

 

 

$62,500

 

 

$533,664

 

Accumulated deficit

 

$1,542,674

 

 

$125,000

 

 

$1,667,674

 

Total stockholders’ deficit

 

$690,924

 

 

$125,000

 

 

$815,924

 

v3.24.1.1.u2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2023
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of restated condensed financial statements

 

 

As Previously Reported

 

 

Adjustments

 

 

As Restated

 

Condensed Balance Sheets as of June 30, 2023

 

 

 

 

 

 

 

 

 

Accrued Expenses - Related Party

 

$-

 

 

$125,000

 

 

$125,000

 

Total current liabilities

 

$872,119

 

 

$125,000

 

 

$997,119

 

Accumulated deficit

 

$1,542,674

 

 

$125,000

 

 

$1,667,674

 

Total stockholders’ deficit

 

$690,924

 

 

$125,000

 

 

$815,924

 

Condensed Statement of Operations for the three months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

$402,912

 

 

$62,500

 

 

$465,412

 

Total operating expenses

 

$467,912

 

 

$62,500

 

 

$530,412

 

Loss before Income tax

 

$471,164

 

 

$62,500

 

 

$533,664

 

Net loss

 

$471,164

 

 

$62,500

 

 

$533,664

 

Condensed Statement of Operations for the six months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

$633,069

 

 

$125,000

 

 

$758,069

 

Total operating expenses

 

$698,069

 

 

$125,000

 

 

$823,069

 

Loss before Income tax

 

$701,376

 

 

$125,000

 

 

$826,376

 

Net loss

 

$701,376

 

 

$125,000

 

 

$826,376

 

Condensed Statement of Cash flows for the six months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$701,376

 

 

$125,000

 

 

$826,376

 

Accrued Expenses

 

$7,083

 

 

$125,000

 

 

$132,083

 

Condensed Statements of Changes in Stockholders’ Deficit for the three months ended March 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$230,212

 

 

$62,500

 

 

$292,712

 

Accumulated deficit

 

$1,071,510

 

 

$62,500

 

 

$1,134,010

 

Total stockholders’ deficit

 

$412,763

 

 

$62,500

 

 

$475,263

 

Condensed Statements of Changes in Stockholders’ Deficit for the three months ended June 30, 2023

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$471,164

 

 

$62,500

 

 

$533,664

 

Accumulated deficit

 

$1,542,674

 

 

$125,000

 

 

$1,667,674

 

Total stockholders’ deficit

 

$690,924

 

 

$125,000

 

 

$815,924

 

v3.24.1.1.u2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Total current liabilities $ 997,199       $ 997,199   $ 826,867  
Accumulated deficit (1,667,674)       (1,667,674)   (841,298)  
Total stockholders' deficit (815,924) $ (475,263) $ (484,851) $ (363,280) (815,924) $ (484,851) $ (595,051) $ (217,514)
Selling, general and administrative 465,412   124,481   758,069 273,403    
Total operating expenses 530,412   124,481   823,069 273,403    
Net loss (533,664) $ (292,712) $ (121,571) $ (145,766) (826,376) (267,337)    
Accrued Expenses         132,083      
Net income/loss         826,376 $ 267,337    
As Previously Reported [Member]                
Accrued expenses - related party 0       0      
Total current liabilities 872,119       872,119      
Accumulated deficit 1,542,674       1,542,674      
Total stockholders' deficit 690,924       690,924      
Selling, general and administrative 402,912       633,069      
Total operating expenses 467,912       698,069      
Loss before Income tax 471,164       701,376      
Net loss 471,164       701,376      
Accrued Expenses         7,083      
Net income/loss         701,376      
Adjustments [Member]                
Accrued expenses - related party 125,000       125,000      
Total current liabilities 125,000       125,000      
Accumulated deficit 125,000       125,000      
Total stockholders' deficit 125,000       125,000      
Selling, general and administrative 62,500       125,000      
Total operating expenses 62,500       125,000      
Loss before Income tax 62,500       125,000      
Net loss 62,500       125,000      
Accrued Expenses         125,000      
Net income/loss         125,000      
As Restated [Member]                
Accrued expenses - related party 125,000       125,000      
Total current liabilities 997,119       997,119      
Accumulated deficit 1,667,674       1,667,674      
Total stockholders' deficit 815,924       815,924      
Selling, general and administrative 465,412       758,069      
Total operating expenses 530,412       823,069      
Loss before Income tax 533,664       826,376      
Net loss $ 533,664       826,376      
Accrued Expenses         132,083      
Net income/loss         $ 826,376      
v3.24.1.1.u2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Allowance for doubtful accounts balance $ 0   $ 0   $ 0
Selling and Marketing costs $ 84,892 $ 122,777 $ 19,090 $ 65,678  
Common stock, shares outstanding 46,158,606   46,158,606   37,103,394
Class A Preferred Stock [Member]          
Potentially dilutive shares 2,265,400   2,265,400    
Letter of Intent [Member]          
Investments $ 15,000   $ 15,000    
Membership Interest Purchase Agreement [Member]          
Investments $ 50,000   $ 50,000    
v3.24.1.1.u2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Note Payable to related party   $ 63,456   $ 63,456   $ 63,456
Accrued Expenses - Related Party   125.000 $ 0 125.000 $ 0  
Accrued interest payable   8,215   8,215   3,173
Note Payable to Shareholder   755,050   755,050   $ 735,050
Chief Executive Officer [Member]            
Increase in note payable to shareholder   $ 20,000 $ 195,000 $ 0 $ 340,000  
Related Party Transaction, Due Date   Dec. 31, 2023        
Vice President [Member] | Series A Preferred Stock [Member]            
Preferred stock, issued   200,001   200,001    
Asset Purchase Agreement [Member]            
Note Payable to related party $ 63,456          
Interest rate 5.00%          
Monthly installments $ 1,902          
Debt term 3 years          
v3.24.1.1.u2
CAPITAL STOCK (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Preferred stock, par value $ 0.0001  
Preferred stock, shares authorized 100,000,000  
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 5,000,000,000 5,000,000,000
Common Stock, Voting Rights The holders of common stock are entitled to one vote for each share held  
Preferred Stock, Voting Rights Each share of Class A Preferred Stock entitles the holder thereof to 50 votes on any matters requiring a shareholder vote of the Company  
Common stock issued in payment, shares 2,945,087  
Common stock issued in payment, value $ 83,000  
Share conversions, common shares 5,060,125  
Share conversions, shares of Class A Preferred Stock 202,405  
Preferred Stock, Conversion Basis Each share of our Class A Preferred Stock is convertible into Common Stock on a one-for-25 basis at the option of the holder  
Liquidation, amount per share $ 1.00  
Chief Executive Officer [Member]    
Share conversions, shares of Class A Preferred Stock 200,001  
Preferred Stock, Conversion Basis shares was determined to be $110,003 based on an assumed conversion at a one-for-25 ratio  
Undesignated Preferred Stock [Member]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 40,000,000 40,000,000
Preferred stock, shares outstanding 0 0
Class A Convertible Preferred Stock [Member]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 60,000,000 60,000,000
Preferred stock, shares outstanding 56,632,599 56,635,000
Class A Preferred Stock [Member]    
Share conversions, common shares 5,060,125  
Share conversions, shares of Class A Preferred Stock 202,405  
Number of preferred stock shares held by CEO 31,092,596  
Preferred stock, shares outstanding 56,632,599  
v3.24.1.1.u2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended
Feb. 28, 2023
Feb. 22, 2023
May 31, 2021
Jun. 30, 2023
Dec. 31, 2022
Accrued Expenses - Related Party       $ 125,000 $ 0
Employment Agreement [Member]          
Unpaid Compensation expense       7,083  
Annual salary $ 85,000   $ 250,000    
Letter of Intent [Member]          
Agreement for the acquisition, description   On February 22, 2023, the Company entered into a Letter of Intent for the acquisition of a Fifty-One Percent (51%) ownership interest in a natural therapeutic products company for total purchase consideration of $7,140,000 consisting of cash payments of $150,000 and $6,990,000 in Company common stock      
Investments       15,000  
Membership Interest Purchase Agreement [Member]          
Agreement for the acquisition, description On February 28, 2023, the Company entered into a Membership Interest Purchase Agreement for the acquisition of Fifty-One Percent (51%) of the Membership Units of a hemp distribution company for total purchase consideration consisting of 230,559 shares of the Company’s common stock and a cash payment of $50,000        
Investments       $ 50,000  

1606 (PK) (USOTC:CBDW)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more 1606 (PK) Charts.
1606 (PK) (USOTC:CBDW)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more 1606 (PK) Charts.